Thomas Jefferson University in Philadelphia is in the process of developing a data base to register medical cannabis patients to study the positive or negative health benefits of consuming cannabis for a wide range of conditions. The prestigious University will do so on mmm.org and their goal is to register 100,000 patients by next year. The database will be overseen by the Lambert Center for the Study of Medical Cannabis and Hemp, which received $3M in fudging in 2016.
Since medical marijuana was legalized in Pennsylvania both private and public institutions have become interested in researching varieties of the cannabis sativa plant for medicinal purposes. By implementing a data base that contain a record of feedback from patients, scientists involved in the study can begin to pinpoint what ailments are best suited for different varieties of cannabis. With time the data should begin to help identify helpful information to the scientific community involved in studying cannabinoids.
Dr. Charles V. Pollack Jr., director of the Lambert Center said, “Current evidence indicates that cannabinoids can be useful in the management of certain types of chronic pain, side effects of chemotherapy and some symptoms of multiple sclerosis—but there is much we still need to learn.”
You may be interested
Featured CCT Interview with CEO of Eden Labs AC BraddockEditor - August 20, 2018
Eden Labs LLC. has been developing and providing plant based extraction equipment out of Seattle, Washington for some of the largest and most respected companies involved in…
VividGro, a Pegasus Capital Advisors Portfolio Company, Announces Partnership with Merida Capital PartnersEditor - August 17, 2018
Partnership to Focus on Growth in Horticultural and Cannabis Industries VividGro, LLC, a portfolio company of private equity firm Pegasus Capital Advisors (Pegasus), today announced it has…
Harborside to Go Public Via Canadian Reverse Takeover in Deal Valued at C$200 MillionEditor - August 15, 2018
Harborside, a California based cannabis dispensary brand with multiple locations, is planning the reverse takeover of Canadian public company Lineage Grow Company Ltd. (CSE: BUDD). Lineage is…